VEA
BPMC

Virtus ETF Advisers’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,777
Closed -$329K 330
2024
Q4
$329K Buy
3,777
+681
+22% +$59.4K 0.13% 231
2024
Q3
$286K Hold
3,096
0.13% 232
2024
Q2
$334K Sell
3,096
-1,450
-32% -$156K 0.16% 207
2024
Q1
$431K Buy
4,546
+654
+17% +$62K 0.23% 188
2023
Q4
$359K Sell
3,892
-1,287
-25% -$119K 0.23% 182
2023
Q3
$260K Sell
5,179
-669
-11% -$33.6K 0.16% 222
2023
Q2
$370K Sell
5,848
-745
-11% -$47.1K 0.22% 143
2023
Q1
$297K Buy
6,593
+119
+2% +$5.35K 0.16% 220
2022
Q4
$284K Buy
6,474
+1,309
+25% +$57.3K 0.15% 292
2022
Q3
$340K Buy
5,165
+76
+1% +$5K 0.14% 258
2022
Q2
$257K Buy
5,089
+1,327
+35% +$67K 0.1% 291
2022
Q1
$240K Hold
3,762
0.11% 187
2021
Q4
$403K Sell
3,762
-1,540
-29% -$165K 0.15% 144
2021
Q3
$545K Sell
5,302
-484
-8% -$49.8K 0.24% 125
2021
Q2
$509K Buy
5,786
+452
+8% +$39.8K 0.21% 140
2021
Q1
$519K Buy
5,334
+146
+3% +$14.2K 0.22% 143
2020
Q4
$582K Sell
5,188
-3,174
-38% -$356K 0.24% 124
2020
Q3
$775K Buy
8,362
+704
+9% +$65.2K 0.41% 94
2020
Q2
$597K Buy
7,658
+2,822
+58% +$220K 0.28% 120
2020
Q1
$283K Sell
4,836
-704
-13% -$41.2K 0.12% 232
2019
Q4
$444K Buy
5,540
+2,744
+98% +$220K 0.07% 224
2019
Q3
$205K Sell
2,796
-155
-5% -$11.4K 0.04% 248
2019
Q2
$278K Sell
2,951
-1,790
-38% -$169K 0.06% 251
2019
Q1
$380K Sell
4,741
-623
-12% -$49.9K 0.81% 39
2018
Q4
$289K Sell
5,364
-956
-15% -$51.5K 0.05% 123
2018
Q3
$493K Sell
6,320
-4,520
-42% -$353K 0.05% 124
2018
Q2
$688K Buy
10,840
+811
+8% +$51.5K 0.61% 105
2018
Q1
$920K Buy
10,029
+5,418
+118% +$497K 0.8% 55
2017
Q4
$348K Sell
4,611
-3,884
-46% -$293K 0.44% 92
2017
Q3
$592K Buy
8,495
+777
+10% +$54.1K 0.08% 80
2017
Q2
$391K Sell
7,718
-2,972
-28% -$151K 0.06% 77
2017
Q1
$427K Buy
10,690
+1,025
+11% +$40.9K 0.08% 112
2016
Q4
$271K Sell
9,665
-3,381
-26% -$94.8K 0.08% 120
2016
Q3
$387K Hold
13,046
0.19% 81
2016
Q2
$264K Buy
13,046
+2,562
+24% +$51.8K 0.2% 75
2016
Q1
$189K Buy
+10,484
New +$189K 0.26% 92